Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
Université Toulouse III - Paul Sabatier · Inserm · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
726
total citations
- FWCI
- 40.22
- Percentile
- 100%
- References
- 207
Citations per year
Authors
3- LBLouis BuscailCorresponding
Université Toulouse III - Paul Sabatier, Inserm, Centre de Recherche en Cancérologie de Toulouse, Hôpital Rangueil
- BBBarbara Bournet
Université Toulouse III - Paul Sabatier, Inserm, Centre de Recherche en Cancérologie de Toulouse, Hôpital Rangueil
- PCPierre Cordelier
Université Toulouse III - Paul Sabatier, Inserm, Centre de Recherche en Cancérologie de Toulouse
Topics & keywords
Topics
Keywords
- KRAS
- Pancreatic cancer
- Medicine
- Cytopathology
- Cancer research
- Adenocarcinoma
- Cancer
- Oncology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.